Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Levtchenko

Showing results (151-160 of 182) with videos related to

Pageof 19
Sort By:
Therapeutic Advances in Chronic Disease|September 9, 2022
Post-authorisation safety study of burosumab use in paediatric, adolescent and adult patients with X-linked hypophosphataemia: rationale and descriptionMaria Luisa Brandi, Gema Ariceta, Signe Sparre Beck-Nielsen, et al.
Kidney International|September 12, 2020
Cystinuria: clinical practice recommendationAude Servais, Kay Thomas, Luca Dello Strologo, et al.
Orphanet Journal of Rare Diseases|November 20, 2014
Clinical utility of chitotriosidase enzyme activity in nephropathic cystinosisMohamed A Elmonem, Samuel H Makar, Lambertus van den Heuvel, et al.
Journal of Inherited Metabolic Disease|September 8, 2021
Human and animal fertility studies in cystinosis reveal signs of obstructive azoospermia, an altered blood-testis barrier and a subtherapeutic effect of cysteamine in testisAhmed Reda, Koenraad Veys, Prashant Kadam, et al.
Therapeutic Advances in Chronic Disease|May 20, 2024
Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: first interim analysisAnnemieke M Boot, Gema Ariceta, Signe Sparre Beck-Nielsen, et al.
Nature Cell Biology|July 12, 2016
Autophagosome-lysosome fusion triggers a lysosomal response mediated by TLR9 and controlled by OCRLMaria Giovanna De Leo, Leopoldo Staiano, Mariella Vicinanza, et al.
Orphanet Journal of Rare Diseases|September 26, 2023
The International X-Linked Hypophosphatemia (XLH) Registry: first interim analysis of baseline demographic, genetic and clinical dataGema Ariceta, Signe Sparre Beck-Nielsen, Annemieke M Boot, et al.
Cells|December 24, 2021
Benefits and Toxicity of Disulfiram in Preclinical Models of Nephropathic CystinosisAnna Taranta, Mohamed A Elmonem, Francesco Bellomo, et al.
Clinical Kidney Journal|July 24, 2020
The ANTENATAL multicentre study to predict postnatal renal outcome in fetuses with posterior urethral valves: objectives and designBénédicte Buffin-Meyer, Julie Klein, Loes F M van der Zanden, et al.
Molecular Genetics and Metabolism|October 2, 2020
The impact of COVID-19 pandemic on the diagnosis and management of inborn errors of metabolism: A global perspectiveMohamed A Elmonem, Amaya Belanger-Quintana, Andrea Bordugo, et al.
Pageof 19

Showing results (151-160 of 182) with videos related to

Sort By:
Pageof 19
Therapeutic Advances in Chronic Disease|September 9, 2022
Post-authorisation safety study of burosumab use in paediatric, adolescent and adult patients with X-linked hypophosphataemia: rationale and descriptionMaria Luisa Brandi, Gema Ariceta, Signe Sparre Beck-Nielsen, et al.
Kidney International|September 12, 2020
Cystinuria: clinical practice recommendationAude Servais, Kay Thomas, Luca Dello Strologo, et al.
Orphanet Journal of Rare Diseases|November 20, 2014
Clinical utility of chitotriosidase enzyme activity in nephropathic cystinosisMohamed A Elmonem, Samuel H Makar, Lambertus van den Heuvel, et al.
Journal of Inherited Metabolic Disease|September 8, 2021
Human and animal fertility studies in cystinosis reveal signs of obstructive azoospermia, an altered blood-testis barrier and a subtherapeutic effect of cysteamine in testisAhmed Reda, Koenraad Veys, Prashant Kadam, et al.
Therapeutic Advances in Chronic Disease|May 20, 2024
Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: first interim analysisAnnemieke M Boot, Gema Ariceta, Signe Sparre Beck-Nielsen, et al.
Nature Cell Biology|July 12, 2016
Autophagosome-lysosome fusion triggers a lysosomal response mediated by TLR9 and controlled by OCRLMaria Giovanna De Leo, Leopoldo Staiano, Mariella Vicinanza, et al.
Orphanet Journal of Rare Diseases|September 26, 2023
The International X-Linked Hypophosphatemia (XLH) Registry: first interim analysis of baseline demographic, genetic and clinical dataGema Ariceta, Signe Sparre Beck-Nielsen, Annemieke M Boot, et al.
Cells|December 24, 2021
Benefits and Toxicity of Disulfiram in Preclinical Models of Nephropathic CystinosisAnna Taranta, Mohamed A Elmonem, Francesco Bellomo, et al.
Clinical Kidney Journal|July 24, 2020
The ANTENATAL multicentre study to predict postnatal renal outcome in fetuses with posterior urethral valves: objectives and designBénédicte Buffin-Meyer, Julie Klein, Loes F M van der Zanden, et al.
Molecular Genetics and Metabolism|October 2, 2020
The impact of COVID-19 pandemic on the diagnosis and management of inborn errors of metabolism: A global perspectiveMohamed A Elmonem, Amaya Belanger-Quintana, Andrea Bordugo, et al.
Pageof 19